Mr Mrs Miss Ms Dr Other

Dr
Jade
Cheng

Patent Attorney

London Office

Life sciences

Telephone. +44 (0)207 776 5100
Email. [email protected]

Experience

Jade joined the Life Sciences group of HGF in February 2022 as a qualified UK and European Patent Attorney.

Prior to being a Patent Attorney, Jade was a postdoctoral fellow at the Medical Research Council Laboratory of Molecular Biology (MRC LMB) in Cambridge. During her time as an academic, she investigated diverse subjects including the blood brain barrier, mechanisms of cell death and embryonic development.

Jade’s experience in academia means she understands the patenting process from academics' point of view and is ideally placed to work alongside universities’ technology transfer departments and their academics.

Jade’s main areas of focus in patent practice are on antibodies, vaccines, medical treatments and sequencing technologies. She has experience with drafting and filing applications, prosecution, freedom-to-operate analyses, third party observations, EPO oppositions and appeals, and providing filing strategies. She also advises clients on prosecution in many foreign jurisdictions.

Jade enjoys being a member of the HGF Venture team with Kerry Rees to provide IP due diligence services to life science investors. As a consequence, Jade also works with early stage companies to help them align their IP strategies with their business plan to maximum the return on investment.

Jade is fluent in English and Cantonese.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

Biochemistry

PHD

Biochemistry

Conferences: 2023

November 21st 2023

LSPN Europe 2023

Attended

Event details

Related News

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

How to Use IP Strategy to Tip the Odds in Your Favour

Porter’s Five Forces model [1] is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …

Read article

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.